In a recent update, influencer Claudia Oshry has made a significant decision regarding her postpartum health journey. After sharing her experiences with postpartum weight-loss three months ago, Oshry announced that she is back on GLP-1 medications. The influencer, known for her role as The Toast host, welcomed her first child, son Reuben, with husband Ben Soffer in May.
:max_bytes(150000):strip_icc():format(jpeg)/claudia-oshry-121625-fb7108243fb440088590e8ec0f55ca2f.jpg)
On December 15, Oshry took to Instagram to document her journey, showcasing herself as she prepared to take GLP-1 medication Zepbound. In the video, she can be seen reaching for a head of cabbage to help dry up her milk supply after breastfeeding, a common home remedy. Zepbound, also known as tirzepatide, is a GLP-1 medication that is typically administered through injection in various areas of the body, aiming to reduce appetite and enhance the body’s sugar and fat metabolism.
The caption of the video, titled “War is over,” seems to indicate Oshry’s relief at ending the breastfeeding phase, as GLP-1 drugs are not considered safe for breastfeeding women. This isn’t Oshry’s first encounter with GLP-1 medications; she previously credited her weight loss of 70 lbs. to taking Ozempic, a similar medication.
In her previous updates, Oshry candidly shared her struggles with weight management while breastfeeding, highlighting the challenges of maintaining balance during this period. Just four days before her recent announcement, she posted a reel of her husband preparing a Weight Watchers recipe as she navigates her nutrition needs as a breastfeeding mother.
As Zepbound may pass into breast milk according to the manufacturer Eli Lilly, Oshry’s use of cabbage leaves to aid in drying up her milk supply reflects her careful consideration of her health and well-being. This decision marks a milestone in Oshry’s postpartum health journey, showcasing her dedication to finding the right balance for her body during this transformative period.
Oshry’s openness and honesty about her experiences serve as an inspiration to many women navigating similar postpartum challenges. Her willingness to share the highs and lows of her journey, including the decision to restart GLP-1 medications, resonates with audiences seeking authentic representations of motherhood and self-care.
This update underscores the importance of individualized health choices during the postpartum period and the significance of prioritizing well-being throughout the various stages of motherhood. Oshry’s decision to restart GLP-1 medications signals a proactive approach to her health, reflecting her commitment to finding solutions that work best for her body and lifestyle.